Leaders in Ion Channel Drug Discovery
Metrion Biosciences is a specialist ion channel contract research organisation providing drug discovery services to pharmaceutical and bioscience customers worldwide.
Metrion invests in new HTS capability and expanded facilities
30 November 2022
Metrion announces the launch of its High Throughput Screening (HTS) capability, as well as the expansion of its state-of-the-art lab and office facilities. Scott Maidment has been appointed as Head of HTS to lead the new service.
Metrion and The KCNC1 Foundation collaborate on development of new ion channel modulators for ultra-rare genetic disorder
7 December 2022
Metrion and The KCNC1 Foundation, a not-for-profit organisation focused on the development of a treatment for an ultra rare genetic disorder, today announced a collaboration to progress a hit identification research project for small molecule modulators of the potassium ion channel Kv3.1, targeting KCNC1-related disorders.
Ion Channel Screening
Cardiac Safety Screening
Integrated Drug Discovery
Metrion Biosciences’ high throughput screening (HTS) overview
6th March 2023
Here we share a short video introducing Metrion’s expanded high throughput screening capabilities. To learn more, or to request a quote, please email firstname.lastname@example.org
- Jack – My Academic and Professional Career So Far!
- Zeki – From Ants to Ion Channels
- Thomas’s Career So Far
- Katie – Expanding my skills to the world of ion channels
- Catherine’s Career So Far
- Yasmin – About Me
RSC Anglo-Nordic Medicinal Chemistry Symposium 2023
June 13th – 16th
Metrion Biosciences are attending RSC Anglo-Nordic Medicinal Chemistry Symposium 2023, taking place on 13th – 16th June 2023 at the Hotel Comwell Borupgaard, Denmark.
Metrions’ Commercial Operations Scientist, Dr. Claire Piochon will be attending the meeting and if you would like to meet with her, please email email@example.com.
This 2.5 day symposium is the third in the very successful series of biannual meetings started in 2017 containing high quality international speakers from industry and academia on topics of Medicinal Chemistry and related enabling technologies. Organised by the Biological and Medicinal Chemistry Sector of the Royal Society of Chemistry, together with Nordic affiliates, the meeting promises to be an exciting and invigorating gathering packed with fantastic opportunities to disseminate knowledge and expand networks.
Cure CLCN4 Scientific Conference 2023
June 16th – 17th
Metrion Biosciences is attending the Cure CLCN4 Scientific Conference 2023 taking place on the 16th – 17th June 2023, in London.
Metrion’s Sales and Marketing Manager, Dr Sophie Rose will be attending the meeting and if you would like to meet with her, please email firstname.lastname@example.org. Sophie will also be attending the conference dinner on the evening of 16th June.
For the second year in a row, this conference will bring together leading academic, clinical and industry speakers from the ion channel, rare disease, and therapeutic discovery fields. Through a series of short talks and panel discussions, we will review the latest knowledge on the biology and clinical aspects of CLCN4-NDC and establish the necessary steps towards the development of therapeutic options for CLCN4, all the way from the early stages of basic research on animal and cellular models to clinical research, drug discovery, and precision medicine.
Our DisPATCHes Newsletter
Receive the latest Ion Channel news and insights to your inbox
Our quarterly newsletter is packed full of the latest Ion Channel news and reviews. We cover events, webinars, research findings, and publications and insights from our team, partners, and distinguished guests. Read the latest edition here.
Let’s work together
What are your specific ion channel and assay needs?
If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.